BackResmed Overview
Resmed Inc.

Resmed Target Price

Analysts' 12-month price predictions for RMD.

Share Price

$249.69

Average Target Price

$266.256.6% upside

4 analysts in the last 4 months

High: $286 | Low: $240

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-05-20Morgan StanleyDavid Bailey$28614.5% upsideOpen
2025-04-24KeyBancBrett Fishbin$2749.7% upsideOpen
2025-04-16Mizuho SecuritiesAnthony Petrone$2656.1% upsideOpen
2025-03-05Stifel Nicolaus$2403.9% downsideOpen
2025-01-31Piper SandlerAdam Maeder$2604.1% upsideOpen
2024-12-12Stifel NicolausJonathan Block$2500.1% upsideOpen
2024-10-01RBC CapitalCraig Wong-Pan$22410.3% downsideOpen
2024-09-23Robert W. BairdJoe Vruwink$28012.1% upsideOpen
2024-09-18Wolfe ResearchMike Polark$18027.9% downsideOpen
2024-04-10RBC CapitalCraig Wong-Pan$18725.1% downsideOpen
2024-04-01Stifel NicolausMike Matson$22410.3% downsideOpen
2023-10-27OppenheimerSuraj Kalia$17529.9% downsideOpen
2023-09-06NeedhamMike Matson$18027.9% downsideOpen
2022-06-20RBC CapitalCraig Wong-Pan$2442.3% downsideOpen
2022-04-29RBC Capital$2336.7% downsideOpen
2021-10-14OppenheimerSuraj Kalia$31225% upsideOpen
2021-08-04Morgan StanleySean Laaman$2500.1% upsideOpen
2021-07-28JefferiesAnthony Petrone$2403.9% downsideOpen